Life Length is the leading company in the field of telomere diagnostics and analyses worldwide. During the past two years, we have carried out major clinical studies for improved cancer diagnosis and prognosis. Now we plan to launch these services to improve patient care quality.
Date | Amount | No. of Investors | |
---|---|---|---|
08/07/2019 | £2,154,390 | 1,085 | View |